Your patients may experience HIV-associated Wasting even when their virus is controlled

Despite viral suppression, patients with HIV may experience unintentional weight loss, loss of lean body mass, and loss of physical endurance. These symptoms are hallmarks of HIV-associated Wasting.1,2

Review this resource to explore information about diagnosing and treating HIV-associated Wasting, as well as its underlying causes.

Pathogenesis of
HIV-associated Wasting

Like the disease itself, the causes of HIV-associated Wasting are complicated and multifactorial. Learn more about the pathogenesis of this syndrome.

Diagnosing
Patients

Diagnosing HIV-associated Wasting properly means you need a complete picture of all the symptoms your patients are experiencing. Use our patient profiles to have a productive conversation with your patients.

Treatment
Options

See the current options for treatment as well as nutrition and exercise recommendations for your patients.

References:
  1. Tang AM, Jacobson DL, Spiegelman D, Knox TA, Wanke C. Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients, 1995 to 2003. J Acquir Immune Defic Syndr. 2005;40(1):70-76.
  2. Dudgeon WD, Phillips KD, Carson JA, Brewer RB, Durstine JL, Hand GA. Counteracting muscle wasting in HIV-infected individuals. HIV Med. 2006;7(5):299-310.
EMD Serono Logo, links to EMD Serono website

© 2021 EMD Serono, Inc. All rights reserved.
EMD Serono is the biopharmaceutical business of Merck KGaA, Darmstadt, Germany. This site contains information that is intended for residents of the United States only and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy. This site contains information that is intended for US residents only.
US-NONE-00024